NDC 70710-1221-01 - CARBIDOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1221
- Requested NDC
- 70710-1221-01
- Package NDCs from labels
- 70710-1221-1, 70710-1221-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2023-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CARBIDOPA - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1221-1 | CARBIDOPA | 100 in 1 BOTTLE | TABLET | 100 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1221 | CARBIDOPA TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230917_c0b1ef99-3092-431a-8fb6-897affd52595.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1221-1 | EA - Each | 70710-1221 | 743b5c3e-a5fd-42ee-b4c0-073005ef0c86 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Cardinal Health 107, LLC | 19d853e2-b8bd-490e-b8d2-b38bec68a139 | 2026-04-16 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Aurobindo Pharma Limited | 4ced8a05-27ac-463f-b331-387e473fdaa1 | 2026-04-09 | Warnings, Adverse reactions | MNX7R8C5VO |
| CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2f8e82d7-6baf-456a-b8c3-4fda6e317902 | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa, Levodopa and Entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Macleods Pharmaceuticals Limited | f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO |
| Calamine | CALAMINE 8%, ZINC OXIDE 8% | Farmacias De Similares TX LLC | 4ecd0add-11c9-cf3b-e063-6394a90adff6 | 2026-04-06 | Warnings | 1K09F3G675 |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 0c630a24-dc51-4601-a5d6-2f9e397a0449 | 2026-04-03 | Warnings, Adverse reactions | MNX7R8C5VO |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 770ba054-fec4-4833-8096-85c3ce3ae830 | 2026-04-01 | Warnings, Adverse reactions | MNX7R8C5VO |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Inc. | ac18e5fa-e2ee-4aa5-8d0f-94b63a076e66 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals NY LLC | 0eb24333-3c11-41dd-888d-3a30d3c9d188 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO |
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Duopa | CARBIDOPA AND LEVODOPA | AbbVie Inc. | 7066d371-dc6a-0d6f-7bed-e5dd4ee912da | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Safecor Health, LLC | 015bc056-ee86-4006-ae7c-689b95e566f4 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.